Tenaya Therapeutics, Inc.·4

Nov 17, 8:34 PM ET

Tingley Whittemore 4

4 · Tenaya Therapeutics, Inc. · Filed Nov 17, 2025

Insider Transaction Report

Form 4
Period: 2025-11-17
Tingley Whittemore
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2025-11-17$1.33/sh2,877$3,826169,926 total
Footnotes (2)
  • [F1]Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025.
  • [F2]Includes 85,838 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4